Neuron-derived neurotrophic factor functions as a novel modulator that enhances endothelial cell function and revascularization processes

Journal of Biological Chemistry

Volumn 289, Issue 20, 2014, Pages 14132-14144

  Ohashi, Koji ^a   Enomoto, Takashi ^a   Joki, Yusuke ^a   Shibata, Rei ^a   Ogura, Yasuhiro ^a   Kataoka, Yoshiyuki ^a   Shimizu, Yuuki ^a   Kambara, Takahiro ^a   Uemura, Yusuke ^a   Yuasa, Daisuke ^a   Matsuo, Kazuhiro ^a   Hayakawa, Satoko ^a   Hiramatsu Ito, Mizuho ^a   Murohara, Toyoaki ^a   Ouchi, Noriyuki ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

MAMMALS; MUSCLE; PHOSPHORYLATION; RECOVERY;

CAPILLARY DENSITY; CARDIO-VASCULAR DISEASE; CELLULAR RESPONSE; HUMAN ENDOTHELIAL CELLS; NEUROTROPHIC FACTORS; REVASCULARIZATION; SECRETED MOLECULES; THERAPEUTIC TARGETS;

ENDOTHELIAL CELLS;

ENDOTHELIAL NITRIC OXIDE SYNTHASE; NEURON DERIVED NEUROTROPHIC FACTOR; NEUROTROPHIC FACTOR; NITRIC OXIDE SYNTHASE; PROTEIN KINASE B; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; VITRONECTIN RECEPTOR; NDNF PROTEIN, MOUSE; NERVE GROWTH FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAPILLARY DENSITY; CELL FUNCTION; CELL HYPOXIA; CELL MIGRATION; CELL SURVIVAL; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; GENE OVEREXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LIMB BLOOD FLOW; LIMB ISCHEMIA; MALE; MOUSE; MUSCLE ISCHEMIA; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN SECRETION; REVASCULARIZATION; SIGNAL TRANSDUCTION; UPREGULATION; ANGIOGENESIS; ANIMAL; BLOOD VESSEL; C57BL MOUSE; CHLOROCEBUS AETHIOPS; CIRCULATION; COS 1 CELL LINE; CYTOLOGY; GENETICS; ISCHEMIA; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHENOTYPE; PHOSPHORYLATION; PHYSIOLOGY;

ANIMALS; BLOOD CIRCULATION; BLOOD VESSELS; CELL SURVIVAL; CERCOPITHECUS AETHIOPS; COS CELLS; ENDOTHELIAL CELLS; HUMANS; ISCHEMIA; MALE; MICE; MICE, INBRED C57BL; NEOVASCULARIZATION, PHYSIOLOGIC; NERVE GROWTH FACTORS; NITRIC OXIDE SYNTHASE TYPE III; PHENOTYPE; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT;

EID: 84901024008     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M114.555789     Document Type: Article

References (49)

1. Roger, V. L., Go, A. S., Lloyd-Jones, D. M., Adams, R. J., Berry, J. D., Brown, T. M., Carnethon, M. R., Dai, S., de Simone, G., Ford, E. S., Fox, C. S., Fullerton, H. J., Gillespie, C., Greenlund, K. J., Hailpern, S. M., Heit, J. A., Ho, P. M., Howard, V. J., Kissela, B. M., Kittner, S. J., Lackland, D. T., Lichtman, J. H., Lisabeth, L. D., Makuc, D. M., Marcus, G. M., Marelli, A., Matchar, D. B., McDermott, M. M., Meigs, J. B., Moy, C. S., Mozaffarian, D., Mussolino, M. E., Nichol, G., Panter, N. P., Rosamond, W. D., Sorlie, P. D., Stafford, R. S., Turan, T. N., Turner, M. B., Wong, N. D., and Wylie-Rosett, J. (2011) Heart disease and stroke statistics: 2011 update: a report from the American Heart Association. Circulation 123, e18-e209
2. Grundy, S. M., Brewer, H. B., Jr., Cleeman, J. I., Smith, S. C., Jr., and Lenfant, C. (2004) Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Arterioscler. Thromb. Vasc. Biol. 24, e13-18
3. Yilmaz, M. B., Biyikoglu, S. F., Akin, Y., Guray, U., Kisacik, H. L., and Korkmaz, S. (2003) Obesity is associated with impaired coronary collateral vessel development. Int. J. Obes. Relat. Metab. Disord. 27, 1541-1545
4. Turhan, H., Yasar, A. S., Erbay, A. R., Yetkin, E., Sasmaz, H., and Sabah, I. (2005) Impaired coronary collateral vessel development in patients with metabolic syndrome. Coron. Artery Dis. 16, 281-285
5. Losordo, D. W., and Dimmeler, S. (2004) Therapeutic angiogenesis and vasculogenesis for ischemic disease: part I: angiogenic cytokines. Circulation 109, 2487-2491
6. Carmeliet, P. (2005) Angiogenesis in life, disease and medicine. Nature 438, 932-936
7. Simons, M. (2005) Angiogenesis: where do we stand now? Circulation 111, 1556-1566
8. Couffinhal, T., Silver, M., Zheng, L. P., Kearney, M., Witzenbichler, B., and Isner, J. M. (1998) Mouse model of angiogenesis. Am. J. Pathol. 152, 1667-1679
9. Emanueli, C., Minasi, A., Zacheo, A., Chao, J., Chao, L., Salis, M. B., Straino, S., Tozzi, M. G., Smith, R., Gaspa, L., Bianchini, G., Stillo, F., Capogrossi, M. C., and Madeddu, P. (2001) Local delivery of human tissue kallikrein gene accelerates spontaneous angiogenesis in mouse model of hindlimb ischemia. Circulation 103, 125-132
10. Goukassian, D. A., Qin, G., Dolan, C., Murayama, T., Silver, M., Curry, C., Eaton, E., Luedemann, C., Ma, H., Asahara, T., Zak, V., Mehta, S., Burg, A., Thorne, T., Kishore, R., and Losordo, D. W. (2007) Tumor necrosis factor-α receptor p75 is required in ischemia-induced neovascularization. Circulation 115, 752-762
11. Schiekofer, S., Galasso, G., Sato, K., Kraus, B. J., and Walsh, K. (2005) Impaired revascularization in a mouse model of type 2 diabetes is associated with dysregulation of a complex angiogenic-regulatory network. Arterioscler. Thromb. Vasc. Biol. 25, 1603-1609
12. Asano, T., Kaneko, E., Shinozaki, S., Imai, Y., Shibayama, M., Chiba, T., Ai, M., Kawakami, A., Asaoka, H., Nakayama, T., Mano, Y., and Shimokado, K. (2007) Hyperbaric oxygen induces basic fibroblast growth factor and hepatocyte growth factor expression, and enhances blood perfusion and muscle regeneration in mouse ischemic hind limbs. Circ. J. 71, 405-411
13. Ouchi, N., Oshima, Y., Ohashi, K., Higuchi, A., Ikegami, C., Izumiya, Y., and Walsh, K. (2008) Follistatin-like 1, a secreted muscle protein, promotes endothelial cell function and revascularization in ischemic tissue through a nitric-oxide synthase-dependent mechanism. J. Biol. Chem. 283, 32802-32811
14. Kuang, X. L., Zhao, X. M., Xu, H. F., Shi, Y. Y., Deng, J. B., and Sun, G. T. (2010) Spatio-temporal expression of a novel neuron-derived neurotrophic factor (NDNF) in mouse brains during development.BMCNeurosci. 11, 137
15. Ouchi, N., Higuchi, A., Ohashi, K., Oshima, Y., Gokce, N., Shibata, R., Akasaki, Y., Shimono, A., and Walsh, K. (2010) Sfrp5 is an anti-inflammatory adipokine that modulates metabolic dysfunction in obesity. Science 329, 454-457
16. Oshima, Y., Ouchi, N., Sato, K., Izumiya, Y., Pimentel, D. R., and Walsh, K. (2008) Follistatin-like 1 is an Akt-regulated cardioprotective factor that is secreted by the heart. Circulation 117, 3099-3108
17. Enomoto, T., Ohashi, K., Shibata, R., Higuchi, A., Maruyama, S., Izumiya, Y., Walsh, K., Murohara, T., and Ouchi, N. (2011) Adipolin/C1qdc2/ CTRP12 protein functions as an adipokine that improves glucose metabolism. J. Biol. Chem. 286, 34552-34558
18. Shibata, R., Ouchi, N., Kihara, S., Sato, K., Funahashi, T., and Walsh, K. (2004) Adiponectin stimulates angiogenesis in response to tissue ischemia through stimulation of amp-activated protein kinase signaling. J. Biol. Chem. 279, 28670-28674
19. Galasso, G., Schiekofer, S., Sato, K., Shibata, R., Handy, D. E., Ouchi, N., Leopold, J. A., Loscalzo, J., and Walsh, K. (2006) Impaired angiogenesis in glutathione peroxidase-1-deficient mice is associated with endothelial progenitor cell dysfunction. Circ. Res. 98, 254-261
20. Ohashi, K., Ouchi, N., Sato, K., Higuchi, A., Ishikawa, T. O., Herschman, H. R., Kihara, S., and Walsh, K. (2009) Adiponectin promotes revascularization of ischemic muscle through a cyclooxygenase 2-dependent mechanism. Mol. Cell. Biol. 29, 3487-3499
21. Ohashi, K., Ouchi, N., Higuchi, A., Shaw, R. J., and Walsh, K. (2010) LKB1 deficiency in Tie2-Cre-expressing cells impairs ischemia-induced angiogenesis. J. Biol. Chem. 285, 22291-22298
22. Ouchi, N., Shibata, R., and Walsh, K. (2005) AMP-activated protein kinase signaling stimulates VEGF expression and angiogenesis in skeletal muscle. Circ. Res. 96, 838-846
23. Takemura, Y., Fukuo, K., Yasuda, O., Inoue, T., Inomata, N., Yokoi, T., Kawamoto, H., Suhara, T., and Ogihara, T. (2004) Fas signaling induces Akt activation and upregulation of endothelial nitric oxide synthase expression. Hypertension 43, 880-884
24. Ogura, Y., Ouchi, N., Ohashi, K., Shibata, R., Kataoka, Y., Kambara, T., Kito, T., Maruyama, S., Yuasa, D., Matsuo, K., Enomoto, T., Uemura, Y., Miyabe, M., Ishii, M., Yamamoto, T., Shimizu, Y., Walsh, K., and Murohara, T. (2012) Therapeutic impact of follistatin-like 1 on myocardial ischemic injury in preclinical animal models. Circulation 126, 1728-1738
25. Cikos, S., Bukovsk?, A., and Koppel, J. (2007) Relative quantification of mRNA: comparison of methods currently used for real-time PCR data analysis. BMC Mol. Biol. 8, 113
26. Nagata, D., Mogi, M., and Walsh, K. (2003) AMP-activated protein kinase (AMPK) signaling in endothelial cells is essential for angiogenesis in response to hypoxic stress. J. Biol. Chem. 278, 31000-31006
27. Ouchi, N., Kobayashi, H., Kihara, S., Kumada, M., Sato, K., Inoue, T., Funahashi, T., and Walsh, K. (2004) Adiponectin stimulates angiogenesis by promoting cross-talk between AMP-activated protein kinase and Akt signaling in endothelial cells. J. Biol. Chem. 279, 1304-1309
28. Greer, S. N., Metcalf, J. L., Wang, Y., and Ohh, M. (2012) The updated biology of hypoxia-inducible factor. EMBO J. 31, 2448-2460
29. Pugazhenthi, S., Nesterova, A., Sable, C., Heidenreich, K. A., Boxer, L. M., Heasley, L. E., and Reusch, J. E. (2000) Akt/protein kinase B up-regulates Bcl-2 expression through cAMP-response element-binding protein. J. Biol. Chem. 275, 10761-10766
30. Fujio, Y., and Walsh, K. (1999) Akt mediates cytoprotection of endothelial cells by vascular endothelial growth factor in an anchorage-dependent manner. J. Biol. Chem. 274, 16349-16354
31. Shiojima, I., and Walsh, K. (2002) Role of Akt signaling in vascular homeostasis and angiogenesis. Circ. Res. 90, 1243-1250
32. Fulton, D., Gratton, J. P., McCabe, T. J., Fontana, J., Fujio, Y., Walsh, K., Franke, T. F., Papapetropoulos, A., and Sessa, W. C. (1999) Regulation ofendothelium-derived nitric oxide production by the protein kinase Akt. Nature 399, 597-601
33. Dimmeler, S., Fleming, I., Fisslthaler, B., Hermann, C., Busse, R., and Zeiher, A. M. (1999) Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature 399, 601-605
34. Luo, Z., Fujio, Y., Kureishi, Y., Rudic, R. D., Daumerie, G., Fulton, D., Sessa, W. C., and Walsh, K. (2000) Acute modulation of endothelial Akt/PKB activity alters nitric oxide-dependent vasomotor activity in vivo. J. Clin. Invest. 106, 493-499
35. Kureishi, Y., Luo, Z., Shiojima, I., Bialik, A., Fulton, D., Lefer, D. J., Sessa, W. C., and Walsh, K. (2000) The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals. Nat. Med. 6, 1004-1010
36. Hynes, R. O. (2002) Integrins: bidirectional, allosteric signaling machines. Cell 110, 673-687
37. Plow, E. F., Haas, T. A., Zhang, L., Loftus, J., and Smith, J. W. (2000) Ligand binding to integrins. J. Biol. Chem. 275, 21785-21788
38. Kireeva, M. L., Lam, S. C., and Lau, L. F. (1998) Adhesion of human umbilical vein endothelial cells to the immediate-early gene product Cyr61 is mediated through integrin αvβ3. J. Biol. Chem. 273, 3090-3096
39. Brooks, P. C., Strömblad, S., Sanders, L. C., von Schalscha, T. L., Aimes, R. T., Stetler-Stevenson, W. G., Quigley, J. P., and Cheresh, D. A. (1996) Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin α v β 3. Cell 85, 683-693
40. Piali, L., Hammel, P., Uherek, C., Bachmann, F., Gisler, R. H., Dunon, D., and Imhof, B. A. (1995) CD31/PECAM-1 is a ligand for α v β 3 integrin involved in adhesion of leukocytes to endothelium. J. Cell Biol. 130, 451-460
41. Tabas, I. (2010) The role of endoplasmic reticulum stress in the progression of atherosclerosis. Circ. Res. 107, 839-850
42. Matsuda, S., Fujita, T., Kajiya, M., Takeda, K., Shiba, H., Kawaguchi, H., and Kurihara, H. (2012) Brain-derived neurotrophic factor induces migration of endothelial cells through a TrkB-ERK-integrin α Vβ3-FAK cascade. J. Cell. Physiol. 227, 2123-2129
43. Kermani, P., and Hempstead, B. (2007) Brain-derived neurotrophic factor: a newly described mediator of angiogenesis. Trends Cardiovasc. Med. 17, 140-143
44. Cantarella, G., Lempereur, L., Presta, M., Ribatti, D., Lombardo, G., Lazarovici, P., Zappalà, G., Pafumi, C., and Bernardini, R. (2002) Nerve growth factor-endothelial cell interaction leads to angiogenesis in vitro and in vivo. FASEB J. 16, 1307-1309
45. Emanueli, C., Salis, M. B., Pinna, A., Graiani, G., Manni, L., and Madeddu, P. (2002) Nerve growth factor promotes angiogenesis and arteriogenesis in ischemic hindlimbs. Circulation 106, 2257-2262
46. Kirchmair, R., Gander, R., Egger, M., Hanley, A., Silver, M., Ritsch, A., Murayama, T., Kaneider, N., Sturm, W., Kearny, M., Fischer-Colbrie, R., Kircher, B., Gaenzer, H., Wiedermann, C. J., Ropper, A. H., Losordo, D. W., Patsch, J. R., and Schratzberger, P. (2004) The neuropeptide secretoneurin acts as a direct angiogenic cytokine in vitro and in vivo. Circulation 109, 777-783
47. Schgoer, W., Theurl, M., Jeschke, J., Beer, A. G., Albrecht, K., Gander, R., Rong, S., Vasiljevic, D., Egger, M., Wolf, A. M., Frauscher, S., Koller, B., Tancevski, I., Patsch, J. R., Schratzberger, P., Piza-Katzer, H., Ritsch, A., Bahlmann, F. H., Fischer-Colbrie, R., Wolf, D., and Kirchmair, R. (2009) Gene therapy with the angiogenic cytokine secretoneurin induces therapeutic angiogenesis by a nitric oxide-dependent mechanism. Circ. Res. 105, 994-1002
48. Connolly, D. T., Heuvelman, D. M., Nelson, R., Olander, J. V., Eppley, B. L., Delfino, J. J., Siegel, N. R., Leimgruber, R. M., and Feder, J. (1989) Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis. J. Clin. Invest. 84, 1470-1478
49. Leung, D. W., Cachianes, G., Kuang, W. J., Goeddel, D. V., and Ferrara, N. (1989) Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 246, 1306-1309